GPT and neoplasm: As a result, our IMD-BPDs accumulating in liver tissue did not induce immune toxicities as evidenced by minimal changes in alanine aminotransferase (ALT) levels upon systemic administration; thus, we were able to focus on optimizing tumor versus blood drug release through linker design.